Kreisman H, Cohen C, Ghezzo H, Vickerson F, Frank H, Wolkove N
Ann Allergy. 1984 Feb;52(2):90-3.
Ipratropium (40 micrograms) and theophylline (oxtriphylline 400 mg) were administered to 24 asthmatics in a randomized double-blind placebo controlled trial. The combination of these agents produced additive bronchodilation for up to two hours, with a 23 percent maximal increase in FEV1. This regimen promises to be safe, effective therapy for patients with asthma.
在一项随机双盲安慰剂对照试验中,对24名哮喘患者给予异丙托溴铵(40微克)和茶碱(多索茶碱400毫克)。这些药物联合使用可产生长达两小时的相加性支气管扩张作用,第一秒用力呼气量(FEV1)最大增加23%。该治疗方案有望成为哮喘患者安全、有效的治疗方法。